The central government plans to provide Covid vaccines to around 25 crore people out of the country total population of 130 crore by July 2021. The target is to procure between 400 and 500 million vaccine doses on equitable access basis. But are we any closer to a vaccine? Let's find out
undefined
Vaccine 1: CovishieldCompany: Serum Insititute of IndiaNumber of volunteers: 1600Status of trial: Phase 3 ongoingType of vaccine: Non-replicating viral vector (chimp adenovirus)
undefined
Vaccine 2: Sputnik VCompany: Dr Reddy's + Gamaleya Research InstituteNumber of volunteers: 76Status of trial: Permission sought for phase 3Type of vaccine: Non-replicating viral vector (human adenovirus)
undefined
Vaccine 3: CovaxinCompany: Bharat BiotechNumber of volunteers: 1125Status of trial: Phase 2 ongoingType of vaccine: Whole virion inactivated vaccine
undefined
Vaccine 4: ZyCov-DCompany: Zydus CadilaNumber of volunteers: 1048Status of trial: Phase 2 ongoingType of vaccine: Plasmid DNA
undefined
Vaccine 5: RBD VaccineCompany: Biologicale + Baylor College of MedicineNumber of volunteers: 400Status of trial: Permission sought for phase 3Type of vaccine: Recombinant protein vaccine
undefined